Ligand Acquires Assets of Icagen, Inc.

Represented Ligand Pharmaceuticals in its acquisition of the core assets of Icagen, Inc.  Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Icagen, Inc. is an early stage drug discovery company focused on neuroscience and rare diseases with research facilities located in Durham, NC and Oro Valley.